Purified Polypeptide Epitopes for Ehrlichia chaffeensis Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for detecting Ehrlichia chaffeensis antibodies are limited by sensitivity and specificity due to the use of impure antigens, leading to cross-reactions with E. canis antibodies in vaccinated animals, necessitating the development of highly purified and specific reagents for accurate diagnosis.
Innovation Solution
The use of purified polypeptides comprising less than 50 contiguous naturally occurring Ehrlichia chaffeensis amino acids, linked with indicator reagents or other sequences, for specific antibody detection and infection diagnosis, which are designed to avoid cross-reactivity with E. canis antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If impure Ehrlichia antigen is used in antibody detection assays, then the assay can be constructed more easily, but the sensitivity and specificity are severely limited due to cross-reactions
Solution Approach 1:
The patent extracts the specific antigenic determinants from the impure Ehrlichia antigen by identifying and isolating the p120 protein and its epitopes. This extraction process removes the cross-reactive components while retaining the specific antigens that bind to anti-E. chaffeensis antibodies, thereby resolving the contradiction between ease of manufacture and measurement precision
Solution Approach 2:
The patent segments the p120 protein into specific epitopic regions and identifies key amino acid sequences that are responsible for specific antibody binding. By segmenting the antigen into its functional components, the patent enables the use of highly specific antigenic determinants in assays, improving specificity without requiring complex purification of entire proteins
2Measurement precision
If highly purified specific reagents are developed to avoid cross-reactions, then the specificity and sensitivity improve, but the complexity of reagent preparation increases
Solution Approach 1:
The patent creates simplified copies of the specific antigenic determinants by synthesizing peptide sequences corresponding to the p120 epitopes. These synthetic peptide copies can be easily produced and conjugated to carrier proteins, providing a straightforward method to obtain highly specific reagents without complex purification procedures
Solution Approach 2:
The patent constructs composite antigens by conjugating the purified p120 protein or its peptide epitopes to carrier proteins such as keyhole limpet hemocyanin (KLH) or bovine serum albumin (BSA). This composite approach enhances the immunogenicity and stability of the specific antigens while maintaining their specificity, thereby improving assay performance without requiring overly complex reagent preparation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach provides enhanced specificity and sensitivity for detecting Ehrlichia chaffeensis infections while avoiding false positives from E. canis vaccinations, enabling accurate and reliable diagnostic methods.
Implementation Method 1
contacting a purified polypeptide comprising SEQ ID NO:1, 2, 3, 4, or 5 with the test sample, under conditions that allow polypeptide/antibody complexes to form
Data Source
AI summary
The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.